Dhingra Kapil Insider Trades

Insider Trading History

Track insider trading activity for Dhingra Kapil. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Replimune Group
Replimune Group REPL
Director
Holding Value $508k 44,500 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 44,500 shares
$7.61
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $36.2k 3,169 shares
Last Trade
Dec 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.6k 3,169 shares
$10.30
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.6k 3,169 shares
$10.30
$11.42
Replimune Group
Replimune Group REPL
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$33k 3,169 shares
$10.40
$11.42
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$108k 63,390 shares
$1.70
$1.74
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $0 0 shares
Last Trade
Aug 19, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$109k 25,000 shares
$4.35
$4.47
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $112k 25,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 25,000 shares
$4.35
$4.47
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $49.2k 30,550 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.2k 30,550 shares
$2.43
$1.61
Replimune Group
Replimune Group REPL
Director
Holding Value $365k 32,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 32,000 shares
$8.40
$11.42
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $58.1k 33,390 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.1k 33,390 shares
$0.93
$1.74
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $52.2k 30,000 shares
Last Trade
Jan 01, 2025 Sale
$168k 176,376 shares
$0.95
$1.74
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $49.2k 30,550 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 30,550 shares
$4.65
$1.61
Replimune Group
Replimune Group REPL
Director
Holding Value $365k 32,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 32,000 shares
$7.73
$11.42
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $26.6k 16,500 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 16,500 shares
$1.82
$1.61
Replimune Group
Replimune Group REPL
Director
Holding Value $288k 25,200 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 25,200 shares
$17.66
$11.42
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $24.2k 15,000 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1k 15,000 shares
$2.14
$1.61
Replimune Group
Replimune Group REPL
Director
Holding Value $188k 16,500 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 33,000 shares
$18.26
$11.42
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $24.2k 15,000 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 15,000 shares
$12.55
$1.61
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $0 0 shares
Last Trade
Apr 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$950k 25,000 shares
$37.99
$38.00
Replimune Group
Replimune Group REPL
Director
Holding Value $188k 16,500 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 16,500 shares
$31.58
$11.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up